View details GLP-1 & Metabolic AOD-9604 AOD-9604 is a synthetic peptide fragment derived from the C-terminus of the somatotropin sequence, studied for its effects on lipolytic and anti-lipogenic pathways and 3-adrenergic signaling
Beta-cell insulin-secretion assays under glucose-dependent conditions, capturing how the GIP-pathway contribution amplifies the GLP-1-mediated insulinotropic effect at glucose concentrations above the secretion threshold
That said, the NF-kB pathway inhibition demonstrated by GLP-1 receptor agonists is directly relevant to psoriasis pathogenesis
They are coordinated under the leadership of Christina Chambers, PhD, MPH, a perinatal epidemiologist and Professor of Pediatrics at the University of California San Diegos School of Medicine in the Center for Better Beginnings
Watch our short webinars to see how advanced testing works Listen to our podcast for patient stories and provider insights When you're ready, schedule a free discovery call to map out your next steps
